跳至主要内容
临床试验/NCT04350645
NCT04350645Unknown不适用

Role of Prophylactic Tranexamic Acid in Reducing Blood Loss During Elective Caesarean Section for Placenta Praevia Major: A Randomized Controlled Study

Universiti Kebangsaan Malaysia Medical Centre1 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2020年3月24日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
发起方
入组人数
30
试验地点
1
主要终点
To evaluate the effect of prophylactic IV tranexamic acid in amount of blood loss during Caesarean section in placenta previa major

研究概览

简要总结

Prophylactic tranexamic acid will reduce blood loss during Caesarean section for placenta praevia

详细描述

Tranexamic acid is a promising agent, easy to administer, cheap, and can be added to the other routine management in hospitals deliveries. This study aims to document the efficacy of intravenous tranexamic acid in reducing blood loss during and after caesarean section in placenta praevia major patients and to assess the Hb and platelet change after its administration.

General objective:

To investigate the effect of prophylactic IV tranexamic acid in reducing blood loss during Caesarean section for placenta praevia major

Specific objectives:

  1. To evaluate the effect of prophylactic IV tranexamic acid in reducing blood loss during Caesarean section up to 2 hours after Caesarean section.
  2. To evaluate the drop in Haemoglobin level postoperatively with the use of prophylactic IV tranexamic acid for Caesarean section for PP major
  3. To examine the effect of tranexamic acid on platelet level for caesarean section for PP major
  4. To observe the side effects of tranexamic acid

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Triple (Participant, Care Provider, Investigator)

入排标准

年龄范围
18 Years 至 45 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • all placenta previa major pregnant women

排除标准

  • Any cardiac disorder or liver disease
  • Patient on anticoagulant therapy
  • History of allergy to tranexamic acid
  • Any contraindication for tranexamic acid

研究组 & 干预措施

Tranexamic acid group

Active Comparator

Tranexamic acid group will receive 1g slow bolus of tranexamic acid over 2 minutes at least 5 minutes before skin incision (at the end of spinal/general anaesthesia)

干预措施: Tranexamic acid injection (Drug)

Control group

Placebo Comparator

The placebo group will receive normal saline 0.9% (same amount as the tranexamic acid)

干预措施: Normal Saline 0.9% (Drug)

结局指标

主要结局

To evaluate the effect of prophylactic IV tranexamic acid in amount of blood loss during Caesarean section in placenta previa major

时间窗: 24 hours

Amount of blood loss in mls

To evaluate the effect of prophylactic IV tranexamic acid in the changes of haemoglobin during Caesarean section in placenta previa major

时间窗: 24 hours

changes of haemoglobin level

次要结局

  • To evaluate the side effects of tranexamic acid(one week)

研究者

发起方
Universiti Kebangsaan Malaysia Medical Centre
申办方类型
Other
责任方
Principal Investigator
主要研究者

Chew Kah Teik

Clinical lecturer and gynaecologist

Universiti Kebangsaan Malaysia Medical Centre

研究点 (1)

Loading locations...

相似试验